The Pharmacy Times® Asthma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the treatment of the chronic lung disease, in which the airways narrow and swell.
April 25th 2024
The findings emphasize a need for guideline-based care delivery for patients with severe asthma, particularly for patients who are facing social disparities within health care.
Study: Asthma, Hay Fever, Other Allergies Not Linked to Mental Health Traits
October 29th 2021Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.
Read More
FDA Approves Dupilumab for Children Aged 6 to 11 With Moderate to Severe Asthma
October 21st 2021The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.
Read More
Study Identifies Non-Th2 Asthma as Unique Disease, Demonstrates Air Pollutant as Likely Contributor
April 21st 2021This is the first study to demonstrate air pollution as a driver of the most challenging type of asthma to treat, the severe non-Th2 subtype, which is non-responsive to current therapies.
Read More
Study: Asthmatics Do Not Have Higher Risk of Death From COVID-19
February 24th 2021Researchers in Australia analyzed data from 57 studies with an overall sample size of 587,280 individuals. Approximately 350,000 people in the pool had been infected with COVID-19 from Asia, Europe, and North and South America.
Read More